Literature DB >> 11040013

Does primary stenting preserve cardiac function in myocardial infarction? A case-control study. NORTH-981 investigators. Network of revascularisation therapy in Hokkaido.

H Sasao1, K Tsuchihashi, M Hase, T Nakata, K Shimamoto.   

Abstract

OBJECTIVE: To investigate whether coronary stenting limits myocardial injury and preserves left ventricular function. DESIGN AND
SETTING: Prospective multicentre case-control study of primary percutaneous transluminal coronary angioplasty (PTCA) with and without stenting, performed in seven cardiovascular centres. SUBJECTS AND METHODS: 45 consecutive patients with acute myocardial infarction who were treated with successful primary stenting (Stent group) and did not have restenosis were paired with 45 matched control subjects with acute myocardial infarction treated by successful primary PTCA without stenting, also with no restenosis (POBA group).
RESULTS: In comparison with the POBA group, the Stent group-especially those patients with a left anterior descending coronary artery lesion-had a smaller hypokinesis area (mean (SD): 15. 1 (20.0) v 34.4 (24.3) chords), reduced hypokinesis area/risk area (25.2 (31.9)% v 58.8 (40.1)%), and a larger ejection fraction (63.3 (10.2)% v 51.7 (11.7)%) evaluated by quantitative left ventriculography using the centerline method. In the Stent group, the correlation between risk area and hypokinesis area was significantly shifted downward. Multiple logistic regression analysis on infarct size limitation (hypokinesis area/risk area < 50%) identified preinfarction angina in all subjects and preinfarction angina and stenting in patients with left anterior descending coronary artery lesions as explanatory factors.
CONCLUSIONS: Primary PTCA using a coronary stent is effective in preventing myocardial injury and restoring left ventricular function in patients with anterior acute myocardial infarction.

Entities:  

Mesh:

Year:  2000        PMID: 11040013      PMCID: PMC1729472          DOI: 10.1136/heart.84.5.515

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.

Authors:  H Ito; T Tomooka; N Sakai; H Yu; Y Higashino; K Fujii; T Masuyama; A Kitabatake; T Minamino
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

2.  Advantages and applications of the centerline method for characterizing regional ventricular function.

Authors:  F H Sheehan; E L Bolson; H T Dodge; D G Mathey; J Schofer; H W Woo
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

3.  Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.

Authors:  M O'Rourke; D Baron; A Keogh; R Kelly; G Nelson; C Barnes; J Raftos; K Graham; K Hillman; H Newman
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

4.  Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction.

Authors:  M E Edep; E M Guarneri; P S Teirstein; P S Phillips; D L Brown
Journal:  Am J Cardiol       Date:  1999-05-01       Impact factor: 2.778

5.  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction.

Authors:  J H O'Keefe; B D Rutherford; D R McConahay; R W Ligon; W L Johnson; L V Giorgi; J E Crockett; B D McCallister; R D Conn; G M Gura
Journal:  Am J Cardiol       Date:  1989-12-01       Impact factor: 2.778

6.  Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.

Authors:  D B Cross; N G Ashton; R M Norris; H D White
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

7.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

8.  Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience.

Authors:  D A Rothbaum; T J Linnemeier; R J Landin; E F Steinmetz; J S Hillis; C C Hallam; R J Noble; M R See
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

9.  Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial.

Authors:  J L Ritchie; K B Davis; D L Williams; J Caldwell; J W Kennedy
Journal:  Circulation       Date:  1984-11       Impact factor: 29.690

10.  Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction.

Authors:  S G Ellis; W W O'Neill; E R Bates; J A Walton; E G Nabel; S W Werns; E J Topol
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.